Melanocortin Receptor 4 (MC4R) - Disease Assessment and Therapeutics Analysis Forecasts to 2024
PUNE, INDIA, March 20, 2018 /EINPresswire.com/ -- WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Melanocortin Receptor 4 - Pipeline Review, H1 2018”
Melanocortin Receptor 4
Overview
Melanocortin Receptor 4 (MC4R) - Melanocortin 4 receptor (MC4R) is a G protein-coupled receptor involved in the hypothalamic leptin-melanocortin signaling pathway. MC4R is encoded by the MC4R gene. Activation of the MC4R plays a key role in the maintenance of energy homeostasis and is associated with suppression of food intake.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/3066585-melanocortin-receptor-4-mc4r-pipeline-review-h1-2018
Top Companies mentioned
AstraZeneca Plc
MallInckrodt Plc
Palatin Technologies Inc
Melanocortin Receptor 4 Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Melanocortin Receptor 4 - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Melanocortin Receptor 4 , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Melanocortin Receptor 4 (MC4R) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 1, 1 and 4 respectively. Similarly, the universities portfolio in Discovery stages comprises 2 molecules, respectively.
Melanocortin Receptor 4 pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Melanocortin Receptor 4 - Competitive Analysis
Key players are making innovative developments in Melanocortin Receptor 4 industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Melanocortin Receptor 4.
The pipeline guide reviews pipeline therapeutics for Melanocortin Receptor 4 by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Melanocortin Receptor 4 therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Melanocortin Receptor 4 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Melanocortin Receptor 4.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3066585-melanocortin-receptor-4-mc4r-pipeline-review-h1-2018
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.